Furthermore, [18F]THK-5351 shows better specificity to PSP-tau than other tau PET tracers [60], [61]: in fact, its uptake was shown to correlate with PSP neuropathology and progressive disease severity [62], [63]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.